Source:http://linkedlifedata.com/resource/pubmed/id/21784368
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-7-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1933-2874
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
247-8
|
pubmed:meshHeading |
pubmed-meshheading:21784368-Biological Markers,
pubmed-meshheading:21784368-Cardiovascular Diseases,
pubmed-meshheading:21784368-Cholesterol, HDL,
pubmed-meshheading:21784368-Chronic Disease,
pubmed-meshheading:21784368-Clinical Trials as Topic,
pubmed-meshheading:21784368-Humans,
pubmed-meshheading:21784368-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:21784368-Kidney Diseases,
pubmed-meshheading:21784368-Triglycerides
|
pubmed:articleTitle |
From the editor.
|
pubmed:publicationType |
Editorial
|